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ABSTRACT
Intrauterine growth restriction (IUGR) reduces skeletal muscle mass in fetuses and offspring.
The objective of this study was to determine if myoblasts (skeletal muscle stem cells) from
maternal inflammation induced intrauterine growth-restricted (MI-IUGR) fetuses are less
responsive to proliferation-stimulating factors in culture. Ovine MI-IUGR fetal myoblasts were
isolated at 125 days of gestational age (dGA, term = 150 dGA), grown for 72 hours in complete
growth media spiked with insulin, tumor necrosis factor α (TNFα), or unspiked (basal), and
analyzed for ex vivo proliferative capacity via a 2 hour EdU pulse. A second set of myoblasts
were differentiated in differentiation media (2% fetal bovine serum) for 96 hours. MI-IUGR
reduced (p < 0.05) fetal weight by ~22% at 125dGA compared to controls. No interacting effects
of experimental group x media condition were observed for proliferation or differentiation rates.
MI-IUGR increased (p < 0.05) myoblast ex vivo proliferation rates relative to controls
independent of media condition. Incubation with insulin increased (p < 0.05) ex vivo myoblast
proliferation rates independent of experimental group. No differences in proliferation rates were
observed in media spiked with TNFα compared to basal media. The response to insulin and the
lack of response to TNFα for proliferation indicate that fetal myoblast proliferation is not
responsive to the effects of cytokines during this stage of development. MI-IUGR myoblasts
exhibited diminished (p < 0.05) biomarkers for ex vivo differentiation rates. The early
differentiation marker, myogenin, was present in fewer (p < 0.06) MI-IUGR myoblasts following
4d differentiation relative to controls; the late differentiation marker, desmin, was also expressed
by fewer (p < 0.05) MI-IUGR myoblasts relative to controls regardless of media condition.
Fewer cells (p < 0.05) cultured in TNFα-spiked media stained positive for desmin relative to
basal and insulin media treatments, regardless of experimental group, indicating that myoblast
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differentiation is responsive to cytokines at the fetal stage. Based on these findings, we conclude
that MI-IUGR creates intrinsic fetal myoblast dysfunction that interferes with their ability to exit
the cell cycle (proceed from proliferation to differentiation), which results in their reduced
capacity to facilitate muscle growth. This helps to explain the hallmark reduction in muscle mass
observed in IUGR-born livestock and humans.
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INTRODUCTION
Livestock subjected to intrauterine growth restriction (IUGR)-inducing conditions exhibit not
only low birth weight, but also increased neonatal mortality, reduced growth efficiency, and
diminished carcass yield and quality (Beede et al., 2019). Maternal stressors that cause
inflammation (e.g. heat stress, maternal overnutrition, illness, maternal undernutrition) cause
placental insufficiency that harshens the intrauterine environment by inducing hypoxia and
nutrient lack in the third trimester (Yates et al., 2011). This insufficiency reduces muscle mass by
impairing fiber growth (Yates et al., 2012), as the limited nutrients are directed away from
developing skeletal muscle and reappropriated to support vital fetal brain and heart development
and growth (Hales and Barker, 2001). Chronic fetal stress during IUGR conditions leads to
adaptive metabolic function by skeletal muscle (Cadaret et al., 2018). Maternal inflammationinduced IUGR (MI-IUGR) fetuses have restricted skeletal muscle growth that in other IUGR
models is associated with myoblast dysfunction (Yates et al., 2014). Myoblasts are the ratelimiting step for late gestational and postnatal skeletal muscle growth (Yates et al., 2012). In
these stages of development, skeletal muscle grows via myofiber hypertrophy during which
muscle stem cells called myoblasts undergo proliferation and differentiation steps followed by
fusion with existing myofibers (Greenwood et al., 1999). Myoblast departure from the
proliferation step is marked by the expression of the early regulatory factor myogenin, and
completion of the differentiation step is marked by the presence of the late structural protein
desmin, exhibited when fusion capacity is achieved (Rantanen et al., 1995; Yates et al., 2014).
Furthermore, myoblast progression through these stages is regulated in part by inflammatory
cytokines including TNFα, which circulate at higher concentrations in IUGR fetuses (Makikallio
et al., 2014; Cadaret et al., 2019). TNFα stimulates proliferation of myoblasts but suppresses
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their differentiation and fusion with myofibers (Kumar et al. 2012; Yates et al., 2018). Elevated
cytokine concentrations also impact the responsiveness to insulin (Cadaret et al., 2018), causing
fetal skeletal muscle cells to compensate by increasing insulin receptor expression. IUGR
triggers a series of metabolic adaptations (Brown et al., 2015) including the increased use of
amino acids as substrates for oxidation to maintain energy production (Thorn et al., 2011).
Myofiber neogenesis ceases before parturition in most mammalian species, so postnatal muscle
fiber repair and growth is facilitated by myoblast incorporation into existing fibers (Messina and
Cossu, 2009). As described by Yates et al. (2018), IUGR-influenced myoblast adaptations persist
into adulthood and carry with them consequences for metabolic health in humans (predisposition
to diabetes and metabolic syndrome) and production performance in livestock (growth
rate/efficiency, muscle mass, carcass quality). Thus, the objective of this study was to determine
the impact of MI-IUGR during the proliferation and differentiation stages of fetal myoblast
development in order to better understand the mechanism of adaptation and potentially identify a
target for therapeutic treatment.

MATERIALS AND METHODS
Animal Model of IUGR
All experiments were approved by the Institutional Animal Care and Use Committee at the
University of Nebraska- Lincoln, which is accredited by AAALAC International. Timed-mated
Polypay ewes were given intravenous injections of lipopolysaccharide from E. coli 055:B5
(Sigma-Aldrich) every 3rd day from dGA 100 to 115 to induce maternal inflammation and
produce the MI-IUGR fetal conditions which are described in Cadaret et al. (2019). Controls
were produced from pair fed ewes injected with an equal volume of physiological saline.
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Primary Myoblast Isolations
At dGA125, fetal necropsies were performed after ewes were euthanized by double barbiturate
overdose. Hindlimb muscles were collected, minced, washed in PBS, and suspended in PBS with
Protease type XIV S. griseus (Sigma-Aldrich; St. Louis, MO) for a 1-hr enzymatic digestion to
liberate myoblasts as previously described (Yates et al., 2014). The cells were isolated by serial
centrifugation, preplated to remove fibroblasts, and plated on culture plates. After an overnight
expansion period in complete growth media (Dulbecco’s modified eagle serum, DMEM; Gibco
+ 20% fetal bovine serum, FBS; Atlas Biologicals), cells were slowly frozen and stored in liquid
nitrogen.
Myoblast Culture Experiments
Myoblasts were rapidly thawed at 37℃ and preplated in DMEM + 10% FBS to purify and
expand populations. They were then plated onto fibronectin coated 6-well tissue culture plates at
5,000 cells well-1. Cells were incubated for 24 hours in complete growth media (DMEM + 20%
FBS) containing no additive (basal), insulin (5mU/mL; HumulinR; Lilly; Indianapolis, IN), or
TNFα (20ng/mL; Sigma). Myoblasts were then pulse-labeled with EdU (10mM, Qiagen) for 2
hours and fixed in suspension with 4% PFA for 10 minutes. Following the protocol outlined by
Posont et al. (2018), myoblasts that had replicated during the 2-hr pulse (i.e. EdU +) were
identified by staining in suspension (ClickIT EdU) followed by analysis on a zEPI flow
cytometer (ORFLO Technologies) with gates set from negative (non-stained) controls. An
additional set of myoblasts were plated and cultured for 4 days in differentiation media (DMEM
+ 2% FBS) with the same media conditions described above. Differentiated myoblasts were
identified by positive staining for myogenin (F5B; 1:50; BD Pharmingen) or desmin (DE-U-10;
1:250; GeneTex) and analyzed by zEPI flow cytometry as described above.
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RESULTS
Fetal biometry at necropsy
Maternofetal inflammation reduced (p < 0.05) dGA-125 fetal weight in MI-IUGR fetuses (2.53 ±
0.28 kg) relative to control fetuses (3.23 ± 0.18 kg) by ~22%. This is consistent with other sheep
models of IUGR (Beede et al., 2019). Moreover, brainweight-to-bodyweight ratio was greater (p
< 0.05) for MI-IUGR fetuses, demonstrating asymmetric growth restriction. All other
morphometric and physiological data are reported by Cadaret et al. (2019).
Fetal Myoblast Proliferation Rates
No interaction was observed between experimental group and media condition for ex vivo
myoblast proliferation rates. (See Figure 1.) MI-IUGR increased (p = 0.03) proliferation rates by
~5%, regardless of media condition. Incubation in insulin-spiked media increased (p < 0.001)
proliferation rates compared to incubation in basal media, regardless of experimental group.
Incubation in TNFα-spiked media did not affect proliferation rates compared to basal media,
regardless of experimental group.
Fetal Myoblast Differentiation Rates
No interaction was observed between experimental group and media condition for ex vivo
myoblast differentiation rates. (See Figure 2.) MI-IUGR reduced (p < 0.05) the percentage of
cells staining positive for myogenin, a marker for early differentiation, indicating that fewer
myoblasts were reaching this stage of differentiation after 4 days in differentiation media.
Furthermore, MI-IUGR reduced (p < 0.05) the percentage of cells staining positive for desmin, a
marker for late differentiation. The percentages of myogenin-positive cells did not differ among
media conditions, but incubation in TNFα-spiked media reduced (p < 0.001) the percentage of
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cells staining positive for desmin compared to incubation in basal media, regardless of
experimental group.

DISCUSSION AND CONCLUSION
In this study, we found that MI-IUGR fetal myoblasts proliferate at greater rates and differentiate
at reduced rates regardless of whether they are being stimulated by insulin, TNFα, or are in an
unstimulated state. The observation of these changes in culture indicates that they are the result
of intrinsic myoblast deficits and not the in vivo fetal conditions. Insulin increased rate of
proliferation in myoblasts from all fetuses to a similar magnitude, indicating that the deficit is not
necessarily a disruption in insulin signaling. TNFα stimulation had no effect on proliferation
rates, indicating that proliferative mechanisms may be less responsive to inflammatory cytokines
in fetal compared to adult myoblasts (Kumar et al., 2012). Conversely, TNFα inhibited late
differentiation, which indicates that fetal mechanisms responsible for differentiation are
responsive to cytokines but are not altered in IUGR fetuses. Further investigation is warranted to
determine the mechanistic cause of this reduction in IUGR fetal myoblast function. Based on
these findings, we conclude that MI-IUGR induces adaptive dysfunction that interferes with the
ability of fetal myoblasts to proceed from proliferation into the differentiation stage, which
results in their reduced capacity to facilitate muscle growth. This helps to explain the hallmark
reduction in muscle mass observed in IUGR-born humans and livestock (Hales and Barker,
2001; Yates et al., 2014). Further study of IUGR myoblast differentiation may help elucidate the
molecular mechanisms underlying this inability to exit the cell cycle, which in turn would
provide a potential therapeutic target to improve muscle growth in IUGR offspring. Future areas
of study may include the postulated desensitization of fetal myoblasts to inflammatory cytokines
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in which chronic exposure induces changes in signaling pathways that eventually limit the ability
to respond to cellular signals for differentiation. Alternatively, they may reveal the postulated
hyper-sensitization of fetal myoblasts to pro-inflammatory cytokines in which MI-IUGR fetal
myoblasts do not respond to growth signals due to enhanced inhibitory regulation by
inflammatory factors. The MI-IUGR model differs slightly from the well characterized
hyperthermia-induced placental insufficiency IUGR (PI-IUGR) model described in Yates et al.
(2014). In the PI-IUGR model, IUGR fetal myoblasts exhibited reduced (p < 0.05) proliferation
compared to the control group, which ultimately led to reduced numbers of differentiated
myoblasts available for use in myogenesis (Yates et al., 2014). This study observed the opposite
effect of IUGR on myoblast proliferation rates, perhaps due to the milder fetal growth restriction
effects of MI-IUGR compared to those of PI-IUGR. Generally, however, similar metabolic
dysfunction and impaired muscle growth have been observed in the two models (Beede et al.,
2019).

In conclusion, identifying and targeting the adaptive mechanisms initiated by IUGR could lead to
the development of the previously mentioned therapeutic treatments to counter the negative
effects and restore normal muscle growth and development with far-reaching implications for the
livestock industry. Reduction of neonate death loss, treatment of low birthweight individuals
resulting in normal skeletal muscle growth, and improved metabolic efficiency would translate to
decreased expense and increased production efficiency on the part of the producer for the
ultimate benefit of all parties.

11
LITERATURE CITED
Beede, K. A., Limesand, S. W., Petersen, J. L., & Yates, D. T. 2019. Real supermodels wear
wool: summarizing the impact of the pregnant sheep as an animal model for adaptive
fetal programming. Anim Front 9:34-43. 10.1093/af/vfz018.
Brown, L. D., Rozance, P. J., Bruce, J. L., Friedman, J. E., Hay, Jr., W. W., and Wesolowski,
S. R. 2015. Limited capacity for glucose oxidation in fetal sheep with intrauterine growth
restriction. Am J Physiol Regul Integr Comp Physiol 309:R920-R928.
10.1152/ajpregu.00197.2015
Cadaret, C. N., Merrick, E. M., Barnes, T. L., Beede, K. A., Posont, R. J., Petersen, J. L.,
and Yates, D. T. 2018. Sustained maternal inflammation during the early third trimester
yields fetal adaptations that impair subsequent skeletal muscle growth and glucose
metabolism in sheep. Transl Anim Sci 2:S14-S18. 10.1093/tas/txy047
Cadaret, C. N., Merrick, E. M., Barnes, T. L., Beede, K. A., Posont, R. J., Petersen, J. L.,
and Yates, D. T. 2019. Sustained maternal inflammation during the early third trimester
yields intrauterine growth restriction, impaired fetal muscle glucose metabolism, and
diminished β cell function in fetal sheep. J Anim Sci. 10.1093/jas/skz321
Greenwood, P., Slepetis, R., Bell, A., and Hermanson, J. 1999. Intrauterine growth retardation is
associated with muscle cell cycle activity, but not myofibre number, in ovine fetal
muscle. Reprod Fertil Dev 11:281-291. 10.1071/RD99054
Hales, C. N., and Barker, D. J. 2001. The thrifty phenotype hypothesis. Br Med Bull 60:5-20.
Kumar, A., Bhatnagar, S., and Paul, P. 2012. TWEAK and TRAF6 regulate skeletal
muscle atrophy. Curr Opin Clin Nutr Metab Care 15:233-239.
10.1097/MCO.obo13e328351c3fc

12
Makikallio, K., Kaukola, T., Tuimala, J., Kingsmore, S., Hallmann, M., and Ojaniemi, M.
2012. Umbilical artery chemokine CCL16 is associated with preterm preeclampsia and
fetal growth restriction. Cytokine 60:377-384. 10.1016/j.cyto.2012.07.008
Messina, G. and Cossu, G. 2009. The origin of embryonic and fetal myoblasts: a role of
Pax3 and Pax7. Genes Dev 23:902-905. 10.1101/gad.1797009
Rantanen, J., Hurme, T., Lukka, R., Heino, J., and Kalimo, H. 1995. Satellite cell proliferation
and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for
two different populations of satellite cells. Lab Invest 72:341-347.
Posont, R. J., Beede, K. A., Limesand, S. W., and Yates, D. T. 2018. Changes in myoblast
responsiveness to TNFα and IL-6 contribute to decreased skeletal muscle mass in
intrauterine growth restricted fetal sheep. Transl Anim Sci 2:44-47. 10.1093/tas/txy038.
Thorn, S. R., Rozance, P. J., Brown, L. D., and Hay, W. W. 2011. The intrauterine growth
restriction phenotype: fetal adaptations and potential implications for later life insulin
resistance and diabetes. Semin Reprod Med 29:225-236. 10.1055/s-0031-1275516
Yates, D. T., Green, A. S., and Limesand, S. W. 2011. Catecholamines mediate multiple
fetal adaptations during placental insufficiency that contribute to intrauterine growth
restriction: lessons from hyperthermic sheep. J Pregnancy 2011:1-9.
10.1155/2011/740408
Yates, D. T., Macko, A. R., Nearing, M., Chen, X., Rhoads, R. P., and Limesand, S. W.
2012. Developmental programming in response to intrauterine growth restriction impairs
myoblast function and skeletal muscle metabolism. J Pregnancy 2012:1-10.
10.1155/2012/631038
Yates, D. T., Clarke, D. S., Macko, A. R., Anderson, M. J., Shelton, L. A., Nearing, M., Allen,

13
R. E., Rhoads, R. P., Limesand, S. W. 2014. Myoblasts from intrauterine growthrestricted sheep fetuses exhibit intrinsic deficiencies in proliferation that contribute to
smaller semitendinosus myofibres. J Physiol 592:3113-3125.
10.1113/jphysiol.2014.272591

14
Figures

Effect
Group
Media
G*M

100
90

Myoblast Proliferation
% Replicating cells/2hr

80
70

Pval
0.03
< 0.001
NS

60
50
40
30
20
10
0
Basal

Insulin
Control

TNFα

MI-IUGR

Figure 1. Ex vivo proliferation rates of myoblasts isolated from MI-IUGR fetal sheep. Data are
shown for control (n = 9) and MI-IUGR (n = 7) fetuses.
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Figure 2. Ex vivo differentiation rates of myoblasts isolated from MI-IUGR fetal sheep. Data are
shown for control (n = 9) and MI-IUGR (n = 7). A. represents % of myoblasts staining positive
for myogenin; B. represents % of myoblasts staining positive for desmin.

